MAM
Samco assigns PR duties to Archer Frères
MUMBAI: Samco Securities, an online discount broker, has assigned Archer Frères Communications to provide them with professional direction for image building, plan media relations and manage content across corporate communications and brand PR.
Archer Frères will work closely with new-age strategic advisor — Pitchfork Partners Strategic Consulting.
Samco Securities actively trades and invests in Indian capital markets and are looking for solutions to complex problems like high brokerage and unproductive capital application.
Samco CEO Jimeet Modi said: “We needed a partner who understands our growth plans and enables us to achieve them through a breakthrough communication plan that challenges norms.”
Archer Frères co-founder Jaideep Shergill: “The stock market can be intimidating experience and as a result Indians are forced to rely on brokers. Samco will help make trading and investing simpler and affordable.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
